Article
Use of BTK Inhibitors in Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma…
Blood and Lymphatic Cancer: Targets and Therapy · 2022 · St-Pierre F, Ma S
Key facts
| Title | Use of BTK Inhibitors in Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL): A Practical Guidance |
|---|---|
| First author | St-Pierre F, Ma S |
| Journal | Blood and Lymphatic Cancer: Targets and Therapy |
| Published | Jul 22, 2022 |
| DOI | 10.2147/BLCTT.S326627 |
| Devices mentioned | K981784 |
| Product codes mentioned | CFN, EMG, EMN, FZS, FZY, GAD, GAI, GDJ, GDO, GEG, GEN, HNQ and 3 more |
At a glance
- 1–9 FDA submissions mentioned
- 10–99 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1